US 10301371
Cyclic monomer and dimer peptides having integrin antagonist activity
granted A61KA61K38/00A61K47/542
Quick answer
US patent 10301371 (Cyclic monomer and dimer peptides having integrin antagonist activity) held by Protagonist Therapeutics, Inc. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61K47/542, A61K47/545, A61K47/60